1. KRAS NF-κB is involved in the development of zinc resistance and reduced curability in prostate cancer.
   Monika Holubova et al, 2014, Metallomics CrossRef
2. Cannabidiol rather than Cannabis sativa extracts inhibit cell growth and induce apoptosis in cervical cancer cells
   Sindiswa T. Lukhele et al, 2016, BMC Complement Altern Med CrossRef
3. Biomarkers to assess the efficiency of treatment with platinum-based drugs: what can metallomics add?
   Thiago de O. Araujo et al, 2014, Metallomics CrossRef
4. The −5 A/G single-nucleotide polymorphism in the core promoter region of MT2A and its effect on allele-specific gene expression and Cd, Zn and Cu levels in laryngeal cancer
   Katarzyna Starska et al, 2014, Toxicology and Applied Pharmacology CrossRef
5. Effects of cisplatin on the LSD1-mediated invasion and metastasis of prostate cancer cells
   Zhi-Yuan Chen et al, 2016 CrossRef
6. Inhibition of Transglutaminase 2 activity increases cisplatin cytotoxicity in a model of human hepatocarcinoma chemotherapy
   Dipak D. Meshram et al, 2017, European Journal of Pharmacology CrossRef
7. The timing of caffeic acid treatment with cisplatin determines sensitization or resistance of ovarian carcinoma cell lines
   R. Sirota et al, 2017, Redox Biology CrossRef
8. Nedaplatin sensitization of cisplatin-resistant human non-small cell lung cancer cells
   HUAN WANG et al, 2016 CrossRef
9. Glutathione Levels and Susceptibility to Chemically Induced Injury in Two Human Prostate Cancer Cell Lines
   Lawrence Lash et al, 2015, Molecules CrossRef
10. Strategies for the development of selenium-based anticancer drugs
    Philippe Collery, 2018, Journal of Trace Elements in Medicine and Biology CrossRef
11. Cisplatin based therapy: the role of the mitogen activated protein kinase signaling pathway
    Iman W. Achkar et al, 2018, J Transl Med CrossRef
12. Protective Effect of Sika Deer (Cervus nippon) Velvet Antler Extract against Cisplatin-Induced Kidney and Liver Injury in a Prostate Cancer PC-3 Cell Xenograft Model
    Yujiao Tang et al, 2018, Journal of Chemistry CrossRef
13. Effects of folic acid on the antiproliferative efficiency of doxorubicin, camptothecin and methyl methanesulfonate in MCF-7 cells by mRNA endpoints
    Muriel Almeida Xavier et al, 2016, Saudi Journal of Biological Sciences CrossRef
14. Selenium Species: Current Status and Potentials in Cancer Prevention and Therapy.
    Andy T. Y. Lau, 0 CrossRef
15. Cisplatin enhances cell stiffness and decreases invasiveness rate in prostate cancer cells by actin accumulation
    Martina Raudenska et al, 2019, Sci Rep CrossRef
16. The discovery and characterization of K-563, a novel inhibitor of the Keap1/Nrf2 pathway produced by Streptomyces sp
    Ran Hori et al, 2019, Cancer Med CrossRef
17. Anti-Cancer Activity of Novel Dihydrotestosterone-Derived Ring A-Condensed Pyrazoles on Androgen Non-Responsive Prostate Cancer Cell Lines
    Gergő Mótyán et al, 2019, IJMS CrossRef
18. In-air Production of 3D Co-culture Tumor Spheroid Hydrogels for Expedited Drug Screening
    Jéssica Antunes et al, 2019, Acta Biomaterialia CrossRef
19. Synthesis, structural characterization, cytotoxicity and encapsulation studies of N,Nʹ-(1, 2-dicyano-1,2-vinylene)-bis(4-hydroxysalicylideneaminato) di(p-chlorobenzyl)tin as potential anticancer drug
    Nur Adibah Mohd Amin et al, 2019 CrossRef
20. Genetic polymorphism of metallothionein 2A and risk of laryngeal cancer in a Polish population
    Katarzyna Starska et al, 2014, Med Oncol CrossRef
21. Celastrol pretreatment as a therapeutic option against cisplatin-induced nephrotoxicity
    Tugce Boran et al, 2019, Toxicol. Res. CrossRef
22. Multimodal Holographic Microscopy: Distinction between Apoptosis and Oncosis
    Jan Balvan et al, 2015, PLoS ONE CrossRef
23. The effect of metallothionein 2A core promoter region single-nucleotide polymorphism on accumulation of toxic metals in sinonasal inverted papilloma tissues
    Katarzyna Starska et al, 2015, Toxicology and Applied Pharmacology CrossRef
24. Metallothionein 2A core promoter region genetic polymorphism and its impact on the risk, tumor behavior, and recurrences of sinonasal inverted papilloma (Schneiderian papilloma)
    Katarzyna Starska et al, 2015, Tumor Biol. CrossRef
25. Identifying therapeutic targets in gastric cancer: the current status and future direction
    Beiqin Yu et al, 2015, Acta Biochim Biophys Sin CrossRef
26. Oxidative Stress Resistance in Metastatic Prostate Cancer: Renewal by Self-Eating
    Jan Balvan et al, 2015, PLoS ONE CrossRef
27. Vitamin D derivatives enhance cytotoxic effects of H 2 O 2 or cisplatin on human keratinocytes
    Anna Piotrowska et al, 2016, Steroids CrossRef
28. Nonylphenol effects on human prostate non tumorigenic cells
    Maurizio Forte et al, 2016, Toxicology CrossRef
29. Targeted SERS nanosensors measure physicochemical gradients and free energy changes in live 3D tumor spheroids
    Lauren E. Jamieson et al, 2016, Nanoscale CrossRef
30. Fully automated two-step assay for detection of metallothionein through magnetic isolation using functionalized γ-Fe2O3 particles
    Miguel Angel Merlos Rodrigo et al, 2016, Journal of Chromatography B CrossRef
31. Amino Acid Profiling of Zinc Resistant Prostate Cancer Cell Lines: Associations With Cancer Progression
    Monika Kratochvilova et al, 2017, Prostate CrossRef
32. Microwave-Assisted Synthesis, Proton Dissociation Processes, and Anticancer Evaluation of Novel D-Ring-Fused Steroidal 5-Amino-1-Arylpyrazoles
    Gergő Mótyán et al, 2019, Applied Sciences CrossRef
33. The Quantitative-Phase Dynamics of Apoptosis and Lytic Cell Death
    Tomas Vicar et al, 2020, Sci Rep CrossRef
34. Kinetics of chloride substitution in the [Pt2(6NNpy)Cl4] complex by L-methionine
    Adrian Topolski, 2020, Inorganica Chimica Acta CrossRef
35. Metallothionein Isoforms as Double Agents - Their Roles in Carcinogenesis, Cancer Progression and Chemoresistance
    Miguel Angel Merlos Rodrigo et al, 2020, Drug Resistance Updates CrossRef
36. tRNALys-Derived Fragment Alleviates Cisplatin-Induced Apoptosis in Prostate Cancer Cells
    Changwon Yang et al, 2021, Pharmaceutics CrossRef
37. Chemotherapeutic drugs: Cell death- and resistance-related signaling pathways. Are they really as smart as the tumor cells?
    Mojtaba Mollaei et al, 2021, Translational Oncology CrossRef
38. Metallothionein-3 promotes cisplatin chemoresistance remodelling in neuroblastoma
    Miguel Angel Merlos Rodrigo et al, 2021, Sci Rep CrossRef
39. Role of π-conjugation on the coordination behaviour, substitution kinetics, DNA/BSA interactions, and in vitro cytotoxicity of carboxamide palladium(ii) complexes
    Reinner O. Omondi et al, 2021, Dalton Trans. CrossRef
40. Menin inhibition suppresses castration-resistant prostate cancer and enhances chemosensitivity
    Chaïma Cherif et al, 2021, Oncogene CrossRef
41. A Combinatorial Approach to Protect Sensory Tissue Against Cisplatin-Induced Ototoxicity
    Nicole K. Febles et al, 2022, Hearing Research CrossRef
42. Research on the Enhancement Mechanism of Dihydromyricetin on the Inhibitory Role of Cisplatin Towards Breast Cancer Cell Activity
    Ke Chunlin et al, 2022, j biomater tissue eng CrossRef
43. The IC-50-time evolution is a new model to improve drug responses consistency of large scale studies
    ABDELKRIM ALILECHE, 2022, F1000Res CrossRef
44. Nobiletin as an inducer of programmed cell death in cancer: a review
    Jun Huang et al, 2022, Apoptosis CrossRef
45. [1,2,4]triazyny – potencjalne leki w chemioterapii nowotworów
    Anna Szymanowska et al, 2021 CrossRef
46. Zebrafish embryos as an in vivo model to investigate cisplatin-induced oxidative stress and apoptosis in mitochondrion-rich ionocytes
    Giun-Yi Hung et al, 2022, Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology CrossRef
47. Anticancer Effects of Propolis Extracts Obtained with the Cold Separation Method on PC-3 and DU-145 Prostate Cancer Cell Lines
    Marek Gogacz et al, 2022, Molecules CrossRef
48. Evaluation of the Cytotoxic Effect of Pd2Spm against Prostate Cancer through Vibrational Microspectroscopies
    Raquel C. Laginha et al, 2023, IJMS CrossRef
49. Anoikis in phenotypic reprogramming of the prostate tumor microenvironment
    Prerna R. Nepali et al, 2023, Front. Endocrinol. CrossRef
50. Cisplatin binding to angiogenin protein: new molecular pathways and targets for the drug's anticancer activity
    Giarita Ferraro et al, 2023, Dalton Trans. CrossRef
51. Greener and sustainable fabrication of DNA/RNA base-pair conjugates by [CuO[HN(C2H5)3[Al2Cl7] nanocatalyst: Emerging drug against prostate cancer
    Parveen Kumar et al, 2024, Sustainable Chemistry and Pharmacy CrossRef
52. An Overview of Altered Pathways Associated with Sensitivity to Platinum-Based Chemotherapy in Neuroendocrine Tumors: Strengths and Prospects
    Erika Stefàno et al, 2024, IJMS CrossRef
53. Nanomedicines in diagnosis and treatment of prostate cancers: an updated review
    Jiajia Wang et al, 2024, Front. Bioeng. Biotechnol. CrossRef
54. Long-term zinc treatment alters the mechanical properties and metabolism of prostate cancer cells
    Jiri Navratil et al, 2024, Cancer Cell Int CrossRef